Agrawal V, Salhotra A, Song J, Gu Z, et al. The feasibility of additional CD19-targeted cellular therapy in relapsed/refractory B-ALL with re-emergence of CD19 antigen after prior CD19-negative relapse. Am J Hematol 2023;98:E38-E40.
PMID: 36413124